CN101456751B - A method for preparing calcium phosphate-based bioceramics by adding zinc oxide whiskers - Google Patents
A method for preparing calcium phosphate-based bioceramics by adding zinc oxide whiskers Download PDFInfo
- Publication number
- CN101456751B CN101456751B CN2009100007851A CN200910000785A CN101456751B CN 101456751 B CN101456751 B CN 101456751B CN 2009100007851 A CN2009100007851 A CN 2009100007851A CN 200910000785 A CN200910000785 A CN 200910000785A CN 101456751 B CN101456751 B CN 101456751B
- Authority
- CN
- China
- Prior art keywords
- zinc oxide
- calcium phosphate
- sample
- ratio
- binder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Landscapes
- Materials For Medical Uses (AREA)
Abstract
本发明涉及一种利用掺加氧化锌晶须制备磷酸钙基生物陶瓷的方法,属于无机非金属材料科学领域。本发明基本实施步骤为:以TCP/HAP纳米复合粉体为主要原料,分别添加不同量的ZnOw,采用机械混合的方法混合均匀;在40MPa成型压力下进行冷压成型,将成型后的试样置于高温炉中烧结,所得样品力学性能好、生物相容性好,并且生物降解速度与骨的生长速度相匹配;本发明的优点在于其设备简单、投资少、生产成本低、所得产品性能高,产品性能可控等优点。The invention relates to a method for preparing calcium phosphate-based bioceramics by adding zinc oxide whiskers, and belongs to the scientific field of inorganic non-metallic materials. The basic implementation steps of the present invention are as follows: take TCP/HAP nanocomposite powder as the main raw material, add different amounts of ZnOw respectively, and mix uniformly by mechanical mixing; carry out cold pressing molding under a molding pressure of 40MPa, and form the sample after molding Sintered in a high-temperature furnace, the obtained sample has good mechanical properties and good biocompatibility, and the biodegradation rate matches the growth rate of the bone; the advantages of the present invention are simple equipment, low investment, low production cost, and high performance of the obtained product. High, controllable product performance and other advantages.
Description
技术领域technical field
本发明涉及一种利用掺加氧化锌晶须制备磷酸钙基生物陶瓷的方法,属于无机非金属材料科学领域,可用于骨移植材料的制备等领域。The invention relates to a method for preparing calcium phosphate-based bioceramics by adding zinc oxide whiskers, which belongs to the scientific field of inorganic non-metallic materials and can be used in the fields of preparation of bone graft materials and the like.
背景技术Background technique
磷酸钙基生物陶瓷因其与天然骨的成分相似和良好的生物相容性,在医学方面的获得广泛应用。磷酸钙生物陶瓷主要包括磷酸三钙和羟基磷灰石。Calcium phosphate-based bioceramics have been widely used in medicine because of their similar composition to natural bone and good biocompatibility. Calcium phosphate bioceramics mainly include tricalcium phosphate and hydroxyapatite.
磷酸三钙(TCP)的最大优势是生物相容性好,植入机体后与骨直接融合,无任何排斥和不良反应。有研究认为,磷酸钙陶瓷不仅有骨引导作用,还具有诱导成骨的作用。但是其降解速度过快,在新生骨长入之前就已经完全降解。不能达到骨替代的目的。The biggest advantage of tricalcium phosphate (TCP) is its good biocompatibility, and it can directly fuse with the bone after implantation without any rejection and adverse reactions. Studies have shown that calcium phosphate ceramics not only have the effect of bone conduction, but also have the effect of inducing osteogenesis. However, its degradation rate is too fast, and it is completely degraded before the new bone grows in. Can not achieve the purpose of bone replacement.
羟基磷灰石(HAP)是人体内硬组织的主要无机成分,20世纪70年代初,日本的青木秀希和美国的Jarcho首次人工合成出HAP,从此其作为硬组织修复材料,一直是骨修复生物医用材料研究领域的热门课题之一。HAP具有良好的生物相容性和骨传导性,能与人体骨良好结合,并对新骨生长有一定的诱导作用。然而纯的HAP物理机械性能不理想,脆性大,并且其降解性能较差,在体内不易降解,减缓了新生骨的长入。Hydroxyapatite (HAP) is the main inorganic component of hard tissue in the human body. In the early 1970s, Hideki Aoki of Japan and Jarcho of the United States synthesized HAP for the first time. It is one of the hot topics in the field of biomedical materials research. HAP has good biocompatibility and osteoconductivity, can be well combined with human bone, and has a certain induction effect on new bone growth. However, pure HAP has unsatisfactory physical and mechanical properties, high brittleness, poor degradation performance, and is not easy to degrade in vivo, which slows down the growth of new bone.
综上所述,单一的磷酸三钙或羟基磷灰石都不能完成骨替代手术,因此需要开发一种新型的复合材料;掺加各种材料来制备磷酸钙基生物陶瓷已经成为该领域的研究热点之一。In summary, neither tricalcium phosphate nor hydroxyapatite alone can complete bone replacement surgery, so it is necessary to develop a new type of composite material; adding various materials to prepare calcium phosphate-based bioceramics has become a research field in this field. One of the hot spots.
锌对于成骨细胞的增殖有特殊的直接刺激作用,而对于破骨细胞有一定的抑制作用。动物实验和临床实验也表明,锌可以刺激骨的生长,有利于提高生物材料的生物活性和降解性能;另外,氧化锌晶须(ZnOw)的加入还可以提高磷酸钙基材料的机械强度。因此,ZnOw掺杂的磷酸钙基陶瓷有望成为新一代的骨组织工程材料。并且,利用掺加ZnOw来制备磷酸钙基生物陶瓷的技术至今未见报道。Zinc has a special direct stimulating effect on the proliferation of osteoblasts, but has a certain inhibitory effect on osteoclasts. Animal experiments and clinical experiments also show that zinc can stimulate bone growth, which is beneficial to improve the bioactivity and degradation performance of biomaterials; in addition, the addition of zinc oxide whiskers (ZnOw) can also improve the mechanical strength of calcium phosphate-based materials. Therefore, ZnOw-doped calcium phosphate-based ceramics are expected to become a new generation of bone tissue engineering materials. Moreover, the technology of preparing calcium phosphate-based bioceramics by doping ZnOw has not been reported so far.
发明内容Contents of the invention
本发明的目的是利用掺加氧化锌晶须的方法来制备性能优异的磷酸钙基生物陶瓷。The purpose of the invention is to prepare calcium phosphate-based bioceramic with excellent performance by using the method of adding zinc oxide whiskers.
本发明的技术方案为:Technical scheme of the present invention is:
1)配料:以磷酸三钙和羟基磷灰石纳米复合粉体为主要原料,其中磷酸三钙与羟基磷灰石的比例为1∶2-5∶2;1) Ingredients: use tricalcium phosphate and hydroxyapatite nanocomposite powder as main raw materials, wherein the ratio of tricalcium phosphate to hydroxyapatite is 1:2-5:2;
2)向步骤1)中的复合粉体中加入氧化锌晶须作为烧结助剂和增韧剂,加入的量为1wt%-3wt%;2) adding zinc oxide whiskers to the composite powder in step 1) as a sintering aid and a toughening agent, the amount added is 1wt%-3wt%;
3)向步骤2)所得的粉料中加入一定量的粘结剂,粘结剂为PVB的酒精溶液;复合粉体质量与粘结剂体积的比例为1∶1-1∶2(g/mL),利用机械混合的方法将其均匀混合1-3小时,混合介质为无水乙醇;3) Add a certain amount of binder to the powder obtained in step 2), the binder is the alcohol solution of PVB; the ratio of composite powder mass to binder volume is 1: 1-1: 2 (g/ mL), using the method of mechanical mixing to uniformly mix it for 1-3 hours, and the mixing medium is absolute ethanol;
4)将混合均匀的原料过筛,粒度为60-200目,然后再根据需要冷压成型;4) Sieve the uniformly mixed raw materials, the particle size is 60-200 mesh, and then cold press molding according to needs;
5)将冷压成型所得的试样置于高温炉中烧结,烧结温度为1000-1300℃,达到所设定温度后保温120-300min,随炉自然冷却至室温即得产品。5) Sinter the sample obtained by cold pressing in a high-temperature furnace at a temperature of 1000-1300°C, keep it warm for 120-300 minutes after reaching the set temperature, and cool naturally to room temperature with the furnace to obtain the product.
有益效果Beneficial effect
本发明提出的掺加ZnOw制备磷酸钙基生物陶瓷的技术,具有以下突出的优点:The technology that the present invention proposes by adding ZnOw to prepare calcium phosphate-based bioceramics has the following prominent advantages:
1)设备简单;投资少;1) The equipment is simple; less investment;
2)生产成本低;2) Low production cost;
3)所得样品力学性能好、生物相容性好,并且生物降解速度与骨的生长速度相匹配;3) The obtained sample has good mechanical properties and good biocompatibility, and the biodegradation rate matches the growth rate of bone;
4)产品性能可控,可以通过调整TCP与HAP的比例和加入的氧化锌晶须的量得到性能不同的产品。4) The performance of the product is controllable, and products with different properties can be obtained by adjusting the ratio of TCP to HAP and the amount of added zinc oxide whiskers.
附图说明Description of drawings
图1含1%ZnOw试样烧结后的XRD图;Fig. 1 contains the XRD figure of 1% ZnOw sample after sintering;
图2含1.5%ZnOw试样烧结后的XRD图;Fig. 2 contains the XRD pattern after sintering of 1.5% ZnOw sample;
图3含2%ZnOw试样烧结后的XRD图;Fig. 3 contains the XRD figure of 2% ZnOw sample after sintering;
图4含2.5%ZnOw试样烧结后的XRD图;Fig. 4 contains the XRD figure of 2.5% ZnOw sample after sintering;
图5含3%ZnOw试样烧结后的XRD图;Fig. 5 contains the XRD figure of 3% ZnOw sample after sintering;
图6含1%ZnOw试样烧结后的SEM图;Fig. 6 contains the SEM image of 1% ZnOw sample after sintering;
图7含1.5%ZnOw试样烧结后的SEM图;Fig. 7 contains the SEM image of 1.5% ZnOw sample after sintering;
图8含2%ZnOw试样烧结后的SEM图;Fig. 8 contains the SEM image of 2% ZnOw sample after sintering;
图9含2.5%ZnOw试样烧结后的SEM图;Fig. 9 contains the SEM image of 2.5% ZnOw sample after sintering;
图10含3%ZnOw试样烧结后的SEM图;Fig. 10 contains the SEM image of 3% ZnOw sample after sintering;
图11试样在模拟体液中降解15d后的SEM图;Figure 11 is the SEM image of the sample degraded in simulated body fluid for 15 days;
具体实施方式Detailed ways
下面结合附图和实施例对本发明作进一步说明。The present invention will be further described below in conjunction with drawings and embodiments.
实施例1Example 1
以TCP和HAP比例为3∶2的纳米复合粉体为主要原料,加入1wt%氧化锌晶须,并加入含量为3wt%的PVB酒精溶液,复合粉体质量与PVB酒精溶液体积的比例为:1∶1.5(g/mL);以无水乙醇为混合介质的条件下充分混合,干燥后过60目筛;在40MPa成型压力下进行冷压成型,将成型后的试样置于高温炉中烧结,烧结温度为1200℃,保温时间180min;对所得试样进行XRD和SEM分析;结果如图1和图6所示。The nanocomposite powder that is 3: 2 is main raw material with TCP and HAP ratio, adds 1wt% zinc oxide whisker, and adds the PVB alcohol solution that content is 3wt%, the ratio of composite powder quality and PVB alcohol solution volume is: 1:1.5 (g/mL); fully mixed with absolute ethanol as the mixed medium, passed through a 60-mesh sieve after drying; cold-pressed at a molding pressure of 40MPa, and the molded sample was placed in a high-temperature furnace Sintering, the sintering temperature is 1200°C, and the holding time is 180min; the obtained sample is analyzed by XRD and SEM; the results are shown in Figure 1 and Figure 6.
实施例2Example 2
以TCP和HAP比例为3∶2的纳米复合粉体为主要原料,加入1.5wt%ZnOw,并加入含量为3wt%的PVB酒精溶液,复合粉体质量与PVB酒精溶液体积的比例为:1∶1.5(g/mL);以无水乙醇为混合介质的条件下充分混合,干燥后过60目筛;在40MPa成型压力下进行冷压成型,将成型后的试样置于高温炉中烧结,烧结温度为1200℃,保温时间180min;对所得试样进行XRD和SEM分析;结果如图2和图7所示。The nanocomposite powder that is 3: 2 is main raw material with TCP and HAP ratio, adds 1.5wt% ZnOw, and adds the PVB alcohol solution that content is 3wt%, the ratio of composite powder quality and PVB alcohol solution volume is: 1: 1.5 (g/mL); fully mixed with absolute ethanol as the mixed medium, passed through a 60-mesh sieve after drying; cold-pressed at a molding pressure of 40MPa, and the molded sample was sintered in a high-temperature furnace. The sintering temperature was 1200°C, and the holding time was 180 minutes; the obtained samples were analyzed by XRD and SEM; the results are shown in Figure 2 and Figure 7 .
实施例3Example 3
以TCP和HAP比例为3∶2的纳米复合粉体为主要原料,加入2wt%ZnOw,并加入含量为3wt%的PVB酒精溶液,复合粉体质量与PVB酒精溶液体积的比例为:1∶1.5(g/mL);以无水乙醇为混合介质的条件下充分混合,干燥后过60目筛;在40MPa成型压力下进行冷压成型,将成型后的试样置于高温炉中烧结,烧结温度为1200℃,保温时间180min;对所得试样进行XRD和SEM分析;结果如图3和图8所示。The nano-composite powder with a ratio of TCP and HAP of 3:2 is the main raw material, 2wt% ZnOw is added, and a PVB alcohol solution with a content of 3wt% is added. The ratio of the composite powder mass to the volume of the PVB alcohol solution is: 1:1.5 (g/mL); fully mixed under the condition of anhydrous ethanol as the mixed medium, passed through a 60-mesh sieve after drying; cold-pressed molding was carried out under a molding pressure of 40MPa, and the molded sample was placed in a high-temperature furnace for sintering, and then sintered The temperature was 1200°C, and the holding time was 180 minutes; XRD and SEM analysis were performed on the obtained sample; the results are shown in Figure 3 and Figure 8 .
实施例4Example 4
以TCP和HAP比例为3∶2的纳米复合粉体为主要原料,加入2.5wt%ZnOw,并加入含量为3wt%的PVB酒精溶液,复合粉体质量与PVB酒精溶液体积的比例为:1∶1.5(g/mL);以无水乙醇为混合介质的条件下充分混合,干燥后过60目筛;在40MPa成型压力下进行冷压成型,将成型后的试样置于高温炉中烧结,烧结温度为1200℃,保温时间180min;对所得试样进行XRD和SEM分析;结果如图4和图9所示。The nanocomposite powder that is 3: 2 is main raw material with TCP and HAP ratio, adds 2.5wt% ZnOw, and adds the PVB alcohol solution that content is 3wt%, the ratio of composite powder quality and PVB alcohol solution volume is: 1: 1.5 (g/mL); fully mixed with absolute ethanol as the mixed medium, passed through a 60-mesh sieve after drying; cold-pressed at a molding pressure of 40MPa, and the molded sample was sintered in a high-temperature furnace. The sintering temperature was 1200°C, and the holding time was 180 minutes; the obtained samples were analyzed by XRD and SEM; the results are shown in Figure 4 and Figure 9 .
实施例5Example 5
以TCP和HAP比例为3∶2的纳米复合粉体为主要原料,加入3wt%ZnOw,并加入含量为3wt%的PVB酒精溶液,复合粉体质量与PVB酒精溶液体积的比例为:1∶1.5(g/mL);以无水乙醇为混合介质的条件下充分混合,干燥后过60目筛;在40MPa成型压力下进行冷压成型,将成型后的试样置于高温炉中烧结,烧结温度为1200℃,保温时间180min;对所得试样进行XRD和SEM分析;结果如图5和图10所示。The nano-composite powder with a ratio of TCP and HAP of 3:2 is the main raw material, 3wt% ZnOw is added, and a PVB alcohol solution with a content of 3wt% is added. The ratio of the composite powder mass to the volume of the PVB alcohol solution is: 1:1.5 (g/mL); fully mixed under the condition of anhydrous ethanol as the mixed medium, passed through a 60-mesh sieve after drying; cold-pressed molding was carried out under a molding pressure of 40MPa, and the molded sample was placed in a high-temperature furnace for sintering, and then sintered The temperature was 1200°C, and the holding time was 180 minutes; XRD and SEM analysis were performed on the obtained sample; the results are shown in Figure 5 and Figure 10 .
以上实施例所得试样的抗弯强度不低于40MPa,在37℃的模拟体液中对其降解性能进行进行测试,其降解速度与骨的长入速度基本一致(图11)。The flexural strength of the sample obtained in the above examples is not less than 40MPa, and its degradation performance is tested in a simulated body fluid at 37°C, and its degradation rate is basically consistent with the bone ingrowth rate (Figure 11).
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009100007851A CN101456751B (en) | 2009-01-09 | 2009-01-09 | A method for preparing calcium phosphate-based bioceramics by adding zinc oxide whiskers |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009100007851A CN101456751B (en) | 2009-01-09 | 2009-01-09 | A method for preparing calcium phosphate-based bioceramics by adding zinc oxide whiskers |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101456751A CN101456751A (en) | 2009-06-17 |
CN101456751B true CN101456751B (en) | 2011-06-29 |
Family
ID=40767909
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009100007851A Expired - Fee Related CN101456751B (en) | 2009-01-09 | 2009-01-09 | A method for preparing calcium phosphate-based bioceramics by adding zinc oxide whiskers |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101456751B (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102211931A (en) * | 2011-03-03 | 2011-10-12 | 北方民族大学 | Method for preparing natural hydroxyapatite biological ceramic by using microwave method |
CN102824655A (en) * | 2012-08-24 | 2012-12-19 | 湖南共创生物功能材料有限责任公司 | Biological artificial bone and preparation method thereof |
CN103845762B (en) * | 2012-11-29 | 2017-04-12 | 中南大学 | Method for preparing porous bone scaffold by laser and increasing performance by adding zinc oxide |
CN103110980B (en) * | 2013-02-17 | 2014-10-08 | 山东建筑大学 | In-situ growth material for treating bone defect or decayed teeth and preparation method thereof |
CN108689699A (en) * | 2018-06-14 | 2018-10-23 | 长沙鹏登生物陶瓷有限公司 | A kind of high-flexibility artificial bone joint ceramic composite and preparation method |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1513806A (en) * | 2003-04-30 | 2004-07-21 | 东南大学 | Calcium-Phosphorous Ceramic Porous Scaffold Materials for Bone Tissue Engineering |
-
2009
- 2009-01-09 CN CN2009100007851A patent/CN101456751B/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1513806A (en) * | 2003-04-30 | 2004-07-21 | 东南大学 | Calcium-Phosphorous Ceramic Porous Scaffold Materials for Bone Tissue Engineering |
Non-Patent Citations (1)
Title |
---|
傅小妮等.双相钙磷生物陶瓷研究进展.《化工进展》.2004,第23卷(第2期),158-161. * |
Also Published As
Publication number | Publication date |
---|---|
CN101456751A (en) | 2009-06-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105194728B (en) | A kind of degradable biological porous ceramic film material, preparation method and applications | |
CN105397090B (en) | A kind of preparation method of porous nickel-titanium/hydroxyapatite composite material | |
CN104152738B (en) | A kind of preparation method of bio-medical porous Nitinol | |
KR102258806B1 (en) | Regenerative medicine material and its manufacturing method and application | |
CN105396175B (en) | Bone cement and preparation method thereof containing calcium citrate | |
CN110054491B (en) | Preparation method of nano zinc oxide doped hydroxyapatite porous bioceramic | |
CN101456751B (en) | A method for preparing calcium phosphate-based bioceramics by adding zinc oxide whiskers | |
CN105251057A (en) | Preparation method of porous titanium/hydroxyapatite composite material | |
CN101407414A (en) | Method for preparing calcium polyphosphate / tricalcium phosphate two-phase biological ceramic | |
CN104030718A (en) | Trace element-doped porous calcium carbonate ceramic, and preparation method and application thereof | |
Zhang et al. | Preparation and characterization of Sr–hardystonite (Sr2ZnSi2O7) for bone repair applications | |
CN101987208A (en) | Multi-phase large-aperture bone regeneration bracket material transformed from cuttlebone and preparation method thereof | |
Nikitina et al. | Preparation and properties of copper-substituted hydroxyapatite powders and ceramics | |
CN104761253A (en) | A functional biomimetic composite biological piezoelectric ceramic material and a preparing method thereof | |
CN104894420A (en) | Titanium-niobium-zirconium-based calcium pyrophosphate biological composite material preparation method | |
Farag et al. | New nano-bioactive glass/magnesium phosphate composites by sol-gel route for bone defect treatment | |
CN114315338B (en) | A kind of Si3N4/CPP composite ceramic material and its preparation method and application | |
CN110054505B (en) | Preparation method of nano-loaded zinc hydroxyapatite porous bioceramic | |
Ramesh et al. | Sintering behaviour and properties of magnesium orthosilicate-hydroxyapatite ceramic | |
Kansız et al. | Chitosan/PVA reinforced boron/strontium multi-substituted hydroxyapatite-based biocomposites: Effects of synthesis pH and coating on the physicochemical, mechanical, and in vitro biological properties of scaffolds | |
CN104548195A (en) | Mesoporous calcium magnesium silicate and polyetheretherketone composite, bone prosthesis as well as preparation method and application of composite | |
CN112919888B (en) | A kind of alumina ceramic whose surface is coated with HA and preparation method thereof | |
CN105272193B (en) | A kind of nanometer hydroxyapatite, tricalcium silicate composite boilogical ceramic and its preparation method and application | |
CN106270516B (en) | The preparation method of double gradient porous NiTi/ hydroxyapatite composite materials | |
CN108424138A (en) | Siliceous modified grain boundary phase hydroxylapatite ceramic, bone injury repair material and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110629 Termination date: 20130109 |